Fråga din vårdgivare om Orbactiv kan interagera med andra mediciner som du tar.
Orbactiv är indicerad för behandling av akuta bakteriella hud- och mjukdelsinfektioner (ABSSSI) hos vuxna.
How to use "orbactiv" in an English sentence
In August 2014, Orbactiv (oritavancin) single dose regimen was FDA approved.
A risk management plan has been developed to ensure that Orbactiv is used as safely as possible.
Based on average whole sale price a complete course of Orbactiv is cheaper than a course of Dalvance or Vibativ for treatment of ABSSSI.
In clinical trials more cases of osteomyelitis were reported in the Orbactiv treated group than in the vancomycin-treated group.
This includes three marketed products: recently approved and launched Vabomere (vaborbactam/meropenem), and established commercial products Orbactiv (oritavancin) and Minocin IV (minocycline).
What benefits of Orbactiv have been shown in studies?
A single dose of Orbactiv is effective for treating ABSSSI because Orbactiv has a half-life of 245 hours (10 days).
Orbactiv is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.
Dalvance is marketed by Chicago-based Durata Therapeutics, and Orbactiv is marketed by Parsippany, New Jersey-based The Medicines Company.
Orbactiv is a week inhibitor of CYP2CP and CYP2C19 and an inducer of CYP3A4 and CYP2D6.
Svenska
Deutsch
Suomi
Français
Norsk
عربى
Български
বাংলা
Český
Dansk
Ελληνικά
Español
עִברִית
हिंदी
Hrvatski
Magyar
Bahasa indonesia
Italiano
日本語
Қазақ
한국어
മലയാളം
मराठी
Bahasa malay
Nederlands
Polski
Português
Română
Русский
Slovenský
Slovenski
Српски
தமிழ்
తెలుగు
ไทย
Tagalog
Turkce
Українська
اردو
Tiếng việt
中文